BamSEC and AlphaSense Join Forces
Learn More

Journey Medical Corporation

NASDAQ: DERM    
Share price (2/6/26): $8.35    
Market cap (2/6/26): $278 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 43 pages Journey Medical Corporation Common Stock (Par Value $0.0001 Per Share) at Market Issuance Sales Agreement
12/34/56
EX-10.2
from 10-Q 14 pages Second Amended and Restated Executive Employment Agreement
12/34/56
EX-10.1
from 10-Q 14 pages First Amended and Restated Executive Employment Agreement
12/34/56
EX-10.23
from 10-K 15 pages Journey Medical Corporation Deferred Compensation Plan
12/34/56
EX-10.1
from 10-Q 99 pages Agreement
12/34/56
EX-10.1
from 8-K 1 page Amendment to the Journey Medical Corporation 2015 Stock Plan
12/34/56
EX-10.2
from 10-Q 30 pages ​ Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because It Is Both (I) Not Material and (II) the Type of Information That the Registrant Treats as Private or Confidential. ​ Second Amended and Restated Exclusive License Agreement
12/34/56
EX-10.1
from 10-Q 29 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because It Is Both (I) Not Material and (II) the Type of Information That the Registrant Treats as Private or Confidential. ​ Exclusive License Agreement ​
12/34/56
EX-10.1
from 8-K 11 pages Journey Medical Corporation Employee Stock Purchase Plan
12/34/56
EX-10.1
from 8-K 7 pages Journey Medical Corporation 2015 Stock Plan Restricted Stock Unit Award Agreement
12/34/56
EX-10.1
from 8-K 1 page Amendment to the Journey Medical Corporation 2015 Stock Plan
12/34/56
EX-10.6
from 10-K 6 pages Shared Services Agreement
12/34/56
EX-10.1
from 8-K 53 pages Asset Purchase Agreement Between Vyne Therapeutics Inc. and Journey Medical Corporation Dated as of January 12, 2022
12/34/56
EX-10.17
from S-1 10 pages Indemnity Agreement
12/34/56
EX-10.16
from S-1 3 pages Journey Medical Corporation Future Advance Promissory Note
12/34/56
EX-10.15
from S-1 7 pages Shared Services Agreement
12/34/56
EX-10.14
from S-1 68 pages Certain Identified Information Has Been Excluded From the Exhibit Because It Both (I) Is Not Material and (II) Would Be Competitively Harmful if Publicly Disclosed. Such Excluded Information Has Been Marked With “[***]. Assignment, License, and Collaboration Agreement by and Among Dr. Reddy’s Laboratories Ltd. and Journey Medical Corporation Entered Into as of June 29, 2021
12/34/56
EX-10.13
from S-1 25 pages Article 1 Definitions
12/34/56
EX-10.12
from S-1 29 pages Article 1 Definitions
12/34/56
EX-10.11
from S-1 2 pages Certain Identified Information Has Been Excluded From the Exhibit Because It Both (I) Is Not Material and (II) Would Be Competitively Harmful if Publicly Disclosed. Such Excluded Information Has Been Marked With “[***]. Amendment 1 to Asset Purchase Agreement
12/34/56